Bharat Biotech | The Den

THE DEN

Bharat Biotech's clinical phase III trials of Covid-19 nasal vaccine completed

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the Co

THE DEN

Bharat Biotech's Covaxin gets approval for 6-12 year olds in India

Bharat Biotech's Covaxin has got drug regulator's approval in India for 6-12 year olds. India has been expanding the vaccine coverage among

THE DEN

Production of Covaxin to be "temporarily slowed down" amid "decrease in demand"

The production of Covaxin will be "temporarily slowed down", the Bharat Biotech said in a late-night statement on Friday as the vaccine make

THE DEN

Bharat Biotech Chairman inform ideal time to take Covid Booster

The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman and Managing Director Kr

To get the updates of the world